Research
Micronutrients & recovery
Activation of PPAR-α by fibrates (e.g., fenofibrate, gemfibrozil) lowers triglycerides and raises HDL cholesterol by increasing fatty acid oxidation and lipoprotein lipase activity.
Fibrate medications help your body burn fat for energy and clear 'bad' fats (triglycerides) from your blood while boosting 'good' cholesterol (HDL). This reduces the risk of heart disease and stroke, especially if you have high triglycerides or metabolic syndrome.
GoodSupportsHIGH confidence
PPAR-α agonists are used for the treatment of dyslipidemia, which is characterized by decreased triglycerides levels and increased HDL-c levels in plasma [117]. This state can be achieved by increasing the production of the major component of HDL-c, called Apolipoprotein A-I and A-II (APO A-I & APO A-II) [118, 119] ... Moreover, PPAR-α PPAR-activation further decreases TG levels by amplifying the expression of lipoprotein lipase (LPL) [120] and inhibiting APO C-III in the liver.
Why this rating
Supported by extensive clinical use and cited studies on lipid profiles.
Source
Peroxisome Proliferator-Activated Receptor Targets for the Treatment of Metabolic Diseases
Francisco Monsalve et al. · Mediators of Inflammation · 2013
DOI 10.1155/2013/549627
narrative_reviewCited 349×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
- Activation of PPAR-γ by thiazolidinedione (TZD) agonists (e.g., pioglitazone, rosiglitazone) improves insulin sensitivity and glycemic control in Type 2 Diabetes Mellitus (T2DM) by promoting lipid storage in adipose tissue, reducing free fatty acid release, and increasing adiponectin levels.Good
- PPAR-γ agonists reduce inflammation in macrophages and vascular cells by inhibiting NF-κB and AP-1 signaling pathways, thereby slowing atherosclerosis progression.Good
Related findings · Micronutrients & recovery
- Trans fats (industrial trans-fatty acids) are unequivocally harmful and should be completely avoided as they raise LDL-C, TGs, and Apo B while lowering HDL-C.Strong
- For menopausal women with osteoporosis, first-line pharmacologic therapies include alendronate, risedronate, zoledronic acid, and denosumab for the prevention of hip, nonvertebral, and vertebral fractures.Strong
- Folic acid fortification of flour prevents neural tube birth defects, and mandatory fortification is more effective than voluntary supplementation alone.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →